152 related articles for article (PubMed ID: 35023463)
1. Polysaccharides to Combat Viruses (COVID-19) and Microbes: New updates.
AlMatar M; Makky EA; Ramli ANM; Kafkas NE; Köksal F
Curr Mol Pharmacol; 2022; 15(6):803-814. PubMed ID: 35023463
[TBL] [Abstract][Full Text] [Related]
2. Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines.
Chen X; Han W; Wang G; Zhao X
Int J Biol Macromol; 2020 Dec; 164():331-343. PubMed ID: 32679328
[TBL] [Abstract][Full Text] [Related]
3. Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses.
Ray B; Ali I; Jana S; Mukherjee S; Pal S; Ray S; Schütz M; Marschall M
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062238
[TBL] [Abstract][Full Text] [Related]
4. Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19).
Andrew M; Jayaraman G
Carbohydr Res; 2021 Jul; 505():108326. PubMed ID: 34015720
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era.
Saini J; Kaur P; Malik N; Lakhawat SS; Sharma PK
Microbiol Res; 2022 Dec; 265():127206. PubMed ID: 36162150
[TBL] [Abstract][Full Text] [Related]
6. Polysaccharides and Their Derivatives as Potential Antiviral Molecules.
Claus-Desbonnet H; Nikly E; Nalbantova V; Karcheva-Bahchevanska D; Ivanova S; Pierre G; Benbassat N; Katsarov P; Michaud P; Lukova P; Delattre C
Viruses; 2022 Feb; 14(2):. PubMed ID: 35216019
[TBL] [Abstract][Full Text] [Related]
7. Layer-By-Layer Nanocoating of Antiviral Polysaccharides on Surfaces to Prevent Coronavirus Infections.
Otto DP; de Villiers MM
Molecules; 2020 Jul; 25(15):. PubMed ID: 32731428
[TBL] [Abstract][Full Text] [Related]
8. Elucidating the Drug Repurposing Spectra of COVID-19 with its Analogues SARS and MERS.
Mishra J; Prasun C; Sahoo PK; Nair MS
Mini Rev Med Chem; 2021; 21(20):3191-3202. PubMed ID: 33632095
[TBL] [Abstract][Full Text] [Related]
9. Antiviral Compounds Based on Natural Astragalus polysaccharides (APS): Research and Foresight in the Strategies for Combating SARS-CoV-2 (COVID-19).
Aleebrahim-Dehkordi E; Heidari-Soureshjani E; Aryan A; Ganjirad Z; Soveyzi F; Hoseinsalari A; Derisi MM; Rafieian-Kopaei M
Mini Rev Med Chem; 2022; 22(17):2299-2307. PubMed ID: 35232341
[TBL] [Abstract][Full Text] [Related]
10. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
Khare P; Sahu U; Pandey SC; Samant M
Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
[TBL] [Abstract][Full Text] [Related]
11. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
Patil AM; Göthert JR; Khairnar V
Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
[TBL] [Abstract][Full Text] [Related]
12. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
[TBL] [Abstract][Full Text] [Related]
13. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
Ye ZW; Jin DY
Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
[TBL] [Abstract][Full Text] [Related]
15. Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism.
Shawon J; Akter Z; Hossen MM; Akter Y; Sayeed A; Junaid M; Afrose SS; Khan MA
Curr Pharm Des; 2020; 26(41):5241-5260. PubMed ID: 33155902
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drugs for SARS-CoV-2 treatment: Current state and perspective.
Bolarin JA; Oluwatoyosi MA; Orege JI; Ayeni EA; Ibrahim YA; Adeyemi SB; Tiamiyu BB; Gbadegesin LA; Akinyemi TO; Odoh CK; Umeobi HI; Adeoye AB
Int Immunopharmacol; 2021 Jan; 90():107228. PubMed ID: 33302035
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of SARS-COV-2 Drug Targets and Pharmacological Aspects in Treating the COVID-19.
Bhavaniramya S; Ramar V; Vishnupriya S; Palaniappan R; Sibiya A; Vaseeharan B
Curr Mol Pharmacol; 2022; 15(2):393-417. PubMed ID: 34382513
[TBL] [Abstract][Full Text] [Related]
18. Mannose-specific plant and microbial lectins as antiviral agents: A review.
Gupta A; Yadav K; Yadav A; Ahmad R; Srivastava A; Kumar D; Khan MA; Dwivedi UN
Glycoconj J; 2024 Feb; 41(1):1-33. PubMed ID: 38244136
[TBL] [Abstract][Full Text] [Related]
19. Drug Discovery of Small Molecules for the Treatment of COVID-19: A Review on Clinical Studies.
Goel B; Bhardwaj N; Tripathi N; Jain SK
Mini Rev Med Chem; 2021; 21(12):1431-1456. PubMed ID: 33371848
[TBL] [Abstract][Full Text] [Related]
20. A Recent Achievement in the Discovery and Development of Vaccines and Therapeutic Agents in the Race for COVID-19 Protection and Treatment.
Kifle ZD; Enyew EF; Mekuria AB
J Evid Based Integr Med; 2021; 26():2515690X211003727. PubMed ID: 33761791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
